Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
04/2012
04/05/2012WO2012009080A3 Device for radiation-activated localized delivery of treatment agents
04/05/2012WO2012006398A3 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin
04/05/2012WO2012003181A3 Solid forms
04/05/2012WO2011162818A3 Lecithin carrier vesicles and methods of making the same
04/05/2012WO2011150073A3 Compositions comprising the nc2 domain of collagen ix and methods of using same
04/05/2012WO2011143201A3 Ratiometric combinatorial drug delivery
04/05/2012WO2011140274A3 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
04/05/2012WO2011135222A3 Use of peptides as transporters intended for the internalization of molecules of interest into target cells
04/05/2012WO2011116152A3 Delivery of agents using interfering nanoparticles
04/05/2012WO2011084638A3 Mesalamine suppository
04/05/2012WO2011020933A8 Liposomes covered with the extracellular domain of the apo2l/trail protein
04/05/2012US20120083537 Tcd based hydrophilic polyurethane dispersions
04/05/2012US20120083535 Adhesive mixture for transdermal delivery of highly plasticizing drugs
04/05/2012US20120083515 Bioadhesive gel based on hydroxyethylcellulose
04/05/2012US20120083453 Treatment using neublastin polypeptides
04/05/2012US20120083446 Novel albumin-free factor viii formulations
04/05/2012US20120083444 Emulsion Method For Preparing Low Residual Solvent Microparticles
04/05/2012US20120083442 Myostatin binding agents
04/05/2012US20120082730 Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
04/05/2012US20120082729 Quick dissolve compositions and tablets based thereon
04/05/2012US20120082725 Composition Comprising Immunogenic Microparticles
04/05/2012US20120082724 Dry mouldable drug formulation
04/05/2012US20120082723 Easily administrable solid preparation
04/05/2012US20120082716 Cytotoxic agents
04/05/2012US20120082709 Compositions and methods for delivery of materials
04/05/2012US20120082703 Pharmaceutical composition and use of the pharmaceutical composition for the treatment, prophylaxis or prevention of neoplastic diseases in humans and animals
04/05/2012US20120082702 Nicotinamide compounds useful as kinase modulators
04/05/2012US20120082632 Topical drug delivery system with dual carriers
04/05/2012CA2813300A1 Recombinant polypeptides for membrane fusion and uses thereof
04/05/2012CA2813147A1 Preparation for improving solubility of poorly soluble drug
04/05/2012CA2813064A1 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres
04/05/2012CA2812510A1 Pharmaceutical composition
04/05/2012CA2812460A1 Amatoxin-conjugates with improved linkers
04/05/2012CA2811667A1 Thiazolidine linker for the conjugation of drugs to antibodies
04/04/2012EP2436700A1 Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
04/04/2012EP2436399A1 Polymeric nano-particles for siRNA delivery using charge interaction and covalent bonding
04/04/2012EP2436398A1 Amatoxin-conjugates with improved linkers
04/04/2012EP2436390A1 Topical Anesthetic Uses of Szeto-Schiller Peptides
04/04/2012EP2436384A2 Aripiprazole oral solution
04/04/2012EP2436383A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
04/04/2012EP2436378A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions
04/04/2012EP2436377A2 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
04/04/2012EP2436374A1 Ovule for vaginal administration of arasertaconazole
04/04/2012EP2435827A1 Peptoid ligands for isolation and treatment of autoimmune t-cells
04/04/2012EP2435477A1 Antigen-binding proteins
04/04/2012EP2435360A2 Nanodiamond particle complexes
04/04/2012EP2435095A2 Immunomodulatory agent-polymeric compounds
04/04/2012EP2435094A2 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
04/04/2012EP2435093A1 Albumin-amyloid peptide conjugates and uses thereof
04/04/2012EP2435092A2 Nanocarriers possessing components with different rates of release
04/04/2012EP2435091A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435090A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435089A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435088A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435087A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435086A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435085A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435084A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435083A2 Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid
04/04/2012EP2435082A1 Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide
04/04/2012EP2435070A2 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
04/04/2012EP2435052A1 Solid oral dosage forms of lamivudine
04/04/2012EP2435045A2 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
04/04/2012EP2434886A1 Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
04/04/2012EP2251011B1 Solid preparation for oral administration
04/04/2012EP2207531B1 Self-emulsifying pharmaceutical compositions of rhein or diacerein
04/04/2012EP1660513B9 A ca6 antigen-specific cytotoxic conjugate and methods of using the same
04/04/2012EP1411861B1 Biodegradable injectable implants and related methods of manufacture and use
04/04/2012EP1397158B1 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
04/04/2012EP1316316B1 Preparations for oral administration
04/04/2012CN1870993B 基于咪唑克生盐或其一种多晶型物的药物组合物 Pharmaceutical compositions based idazoxan salt or a polymorph of
04/04/2012CN1630510B Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
04/04/2012CN1404399B Novel non-antigenic mucosal adjuvant formulation for modulating the effects of substances, including vaccine antigens in contact with mucosal body surface
04/04/2012CN102405278A 可切换的亲和力结合剂 Switchable affinity binding agent
04/04/2012CN102405236A 改进的抗-tnfr1多肽,抗体可变结构域和拮抗剂 Improved anti -tnfr1 polypeptide, antibody variable domains and antagonists
04/04/2012CN102405060A Multispecific peptides
04/04/2012CN102405059A Structured peptide processing
04/04/2012CN102405044A 含有单萜的治疗组合物 Monoterpene-containing therapeutic composition
04/04/2012CN102405042A 多孔硅药物洗脱颗粒 Drug-eluting particles of porous silicon
04/04/2012CN102405039A 包括含联结基团的聚合物的化妆品或皮肤用组合物、和化妆处理方法 Including linking group containing polymer cosmetic or dermatological compositions, and cosmetic treatment method
04/04/2012CN102399808A 一种可生物降解的非病毒基因载体及其制备方法和应用 A can support its preparation method and application of bio-degradable non-viral gene
04/04/2012CN102399378A 一种温度敏感的壳聚糖水凝胶及其制备方法 A temperature sensitive hydrogel chitosan and its preparation method
04/04/2012CN102399369A 对氨基酸敏感的超分子聚合物胶束药物载体的制备方法 The amino acid-sensitive supramolecular polymer micelle preparation of the drug carrier
04/04/2012CN102399347A 一种适宜制备双敏型抗肿瘤纳米粒的壳聚糖衍生物及其制备方法 A chitosan derivative and preparation method Unika type suitable for the preparation of anti-tumor nanoparticles
04/04/2012CN102399301A 两亲性魔芋葡甘聚糖胆固醇接枝物的制备方法及用途 Amphiphilic KGM cholesterol graft preparation method and uses
04/04/2012CN102399295A Low-sulfhydrylation-modification-degree biocompatible high-molecular sulfhydrylation derivatives, cross-linking material thereof, and purpose thereof
04/04/2012CN102399293A 一种与纤维蛋白特异结合的重组蛋白及其应用 One kind of fibrin-specific binding of the recombinant protein and its application
04/04/2012CN102397594A X线下可显影的栓塞微粒及其制备方法和应用 Embolic particles and its preparation method and application can be developed under the X-ray
04/04/2012CN102397593A X线下可显影的栓塞微粒及其制备方法和应用 Embolic particles and its preparation method and application can be developed under the X-ray
04/04/2012CN102397592A 一种蛋白线的浸渍工艺 Impregnation process a protein line
04/04/2012CN102397559A Broad spectrum type influenza vaccine and preparation method thereof
04/04/2012CN102397558A Positioning pegylation modified compound of Exendin-4 analog and application thereof
04/04/2012CN102397557A Modification method for gold nanorods and gold nanorods-functional molecule composite
04/04/2012CN102397556A 鸭病毒性肝炎活疫苗用耐热保护剂及其制备方法和应用 Duck hepatitis vaccine with heat-resistant protective agent and its preparation method and application
04/04/2012CN102397555A Veterinary use soluble powder accessory and preparation method thereof
04/04/2012CN102397554A 一种肿瘤靶向双载药递释系统及其制备方法 A dual drug release delivery system and its preparation method tumor targeting
04/04/2012CN102397553A Method for improving drug release in carbon nano tube drug delivery system by displacement object
04/04/2012CN102397546A 一种用于嗅觉或味觉敏感型动物的药物给药方法 Drug administration method for smell or taste-sensitive animals
04/04/2012CN102397545A 一种用于光动力治疗的纳米光敏剂给药系统及其制备方法 Nano photosensitizer delivery system and its preparation method for photodynamic therapy
04/04/2012CN102397536A 注射用三磷酸腺苷辅酶胰岛素及其生产工艺 Coenzyme adenosine triphosphate injection of insulin and its production process